Rivaroxaban Market to Surpass US$ 7.0 Billion by 2026

Rivaroxaban Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026

REPORT DESCRIPTION Rivaroxaban Market – Overview Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto.

Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Rivaroxaban was discovered by Bayer and is being jointly developed with Janssen Research & Development, LLC. Xarelto is approved for indications such as stroke prevention in non-valvular atrial fibrillation, pulmonary embolism, deep vein thrombosis, prevention of recurrent venous thromboembolism (VTE), prevention of VTE after elective hip and knee replacement surgery, and secondary prevention after acute coronary syndrome.

In September 2008, the drug received CE approval for venous thromboembolism in adults undergoing knee and hip replacement surgeries and in 2011, it was approved by the U.S. Food and Drug Administration (FDA) for the same indication. Xarelto is approved in over 130 countries by respective regulatory bodies.

REPORT DESCRIPTION Rivaroxaban Market Taxonomy:

By Strength: 10 mg 15 mg 20 mg

By Application: Deep Vein Thrombosis Prophylaxis Pulmonary Embolism

By Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Pharmacies Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1962

REPORT DESCRIPTION Rivaroxaban Market – Key Players Major players operating in the global rivaroxaban market include Janssen Pharmaceuticals Inc. and Bayer AG. Market players strategize to strengthen their foot hold in the market in spite of high cost by implementing cost-effective treatment schemes. For instance, Janssen Pharmaceuticals offer Xarelto manufacturer coupon or patient assistance program to lower the cost of the drug.

Dreadful injuries caused due to Xarelto, has led the company face many legal issues in the U.S. market. For instance, as of January 30, 2018, Bayer Group had been served in the U.S. with around 22,000 claims of Xarelto for personal injuries from the use of Xarelto, which includes cerebral, gastrointestinal or other bleeding and death causes. On clearance of the claims, the market of the product is expected to be affected in terms of revenue.

Get More Inf @ https://www.coherentmarketinsights.com/market-insight/rivaroxaban-market-1962

ABOUT COHERENT MARKET INSIGHTS

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES

CUSTOMIZED RESEARCH CONSULT STUDIES

SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

      

Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies

ABOUT US KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+ Insights Published Per Year

150+

Consulting Projects Till Date

125+

Clients Worldwide Per Year

110+

COUNTRY ANALYSIS

CONSULT PROJECTS SURVEY RESEARCH

EXCEL FORECAST DATABASE

COMPETITIVE ASSESSMENT

TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702